Psoas major muscle mass and upper limb muscle strength are the main factors influencing the rate of HDL-cholesterol within the target in T2DM patients-Reference-Cited by-同舟云学术

Psoas major muscle mass and upper limb muscle strength are the main factors influencing the rate of HDL-cholesterol within the target in T2DM patients

Published:2023-09-20 Issue: Volume: Page:
ISSN:
Container-title:
language:
Short-container-title:

Author:

Guo Shanshan¹,Han Zhilin²,Cheng Wei³,Zhang Zhitian²,Liu Jiaojiao²,Wang Yongjian¹,Wang Xiangyu²,Yan Hongmei²,Wang Ru¹

Affiliation:

1. Shanghai University of Sport

2. Fudan University

3. Yangpu Hospital, Tongji University

Abstract

Abstract Background Achieving lipid control standards is one of the most important measures to slow down the development of diabetic complications. Clinically, effective drugs have been widely used to reduce low-density lipoprotein cholesterol (LDL-c) and triglycerides (TG). However, there are no effective drugs to increase high-density lipoprotein cholesterol (HDL-c). Studies have shown that exercise can improve HDL-c, so this study intends to investigate the association between muscle mass/muscle strength at different sites and HDL-c to provide clinical evidence to develop precise exercise therapy in the future. Methods We included 2 populations to analyze the relationship between muscle and HDL-c in two aspects: muscle mass and muscle strength. The first study population, including 218 participants, was recruited from inpatients with T2DM in the Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University between February 2017 and December 2020. The second study population, including 138 participants, was recruited from patients with T2DM in Shanghai Yangpu District Central Hospital from June to December 2021. Both groups were analyzed to determine the relationship between psoas major muscle (PMM) mass and muscle strength at different sites and HDL-c. Results The results showed that PMM mass and HDL-c were independently associated and that lower limb muscle strength was not associated with HDL-c. In addition, the odds of achieving the HDL-c target increased with the increase in biceps, triceps and deltoids after adjustment by weight. Furthermore, there were no significant interactions in the trend test for the correlation between PMM mass or upper limb muscle strength and HDL-c between age, sex, and BMI after stratification in the subgroup analysis. Conclusion Our study demonstrates that greater PMM mass and upper limb muscle strength are beneficial for reaching HDL-c targets in certain T2DM patients. This suggests that in clinical practice, specific training of PMM mass and upper limb muscle strength can improve HDL-c in those patients.

Publisher

Research Square Platform LLC

Reference41 articles.

1. Li Y, Teng D, Shi X, Qin G, Qin Y, Quan H, Shi B, Sun H, Ba J, Chen B et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study. Bmj 2020, 369:m99710.1136/bmj.m997.

2. Ling JZJ, Montvida O, Khunti K, Zhang AL, Xue CC, Paul SK. Therapeutic inertia in the management of dyslipidemia and hypertension in incident type 2 diabetes and the resulting risk factor burden: Real-world evidence from primary care. Diabetes, Obesity & Metabolism 2021, 23:1518-153110.1111/dom.14364.

3. Ji L, Hu D, Pan C, Weng J, Huo Y, Ma C, Mu Y, Hao C, Ji Q, Ran X et al. Primacy of the 3B approach to control risk factors for cardiovascular disease in type 2 diabetes patients. The American Journal of Medicine 2013, 126:925.e911-925.e92210.1016/j.amjmed.2013.02.035.

4. Huang Y, Li J, Zhu X, Sun J, Ji L, Hu D, Pan C, Tan W, Jiang S, Tao X. Relationship between healthy lifestyle behaviors and cardiovascular risk factors in Chinese patients with type 2 diabetes mellitus: a subanalysis of the CCMR-3B STUDY. Acta Diabetologica 2017, 54:569-57910.1007/s00592-017-0981-2.

5. Tzoulaki I, Elliott P, Kontis V, Ezzati M. Worldwide Exposures to Cardiovascular Risk Factors and Associated Health Effects: Current Knowledge and Data Gaps. Circulation 2016, 133:2314-233310.1161/CIRCULATIONAHA.115.008718.